330 related articles for article (PubMed ID: 9245560)
1. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis.
Mizumoto M; Arii S; Furutani M; Nakamura T; Ishigami S; Monden K; Ishiguro S; Fujita S; Imamura M
J Surg Res; 1997 Jul; 70(2):124-33. PubMed ID: 9245560
[TBL] [Abstract][Full Text] [Related]
2. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
3. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
4. Increased renal expression of nitric oxide synthase type III in cirrhotic rats with ascites.
Bosch-Marcé M; Morales-Ruiz M; Jiménez W; Bordas N; Solé M; Ros J; Deulofeu R; Arroyo V; Rivera F; Rodés J
Hepatology; 1998 May; 27(5):1191-9. PubMed ID: 9581670
[TBL] [Abstract][Full Text] [Related]
5. [Nitric oxide in pathogenesis of cirrhotic portal hypertension in rats and its hemodynamic effects].
Zhang J; Zhou H
Zhonghua Wai Ke Za Zhi; 1998 May; 36(5):317-9. PubMed ID: 11825400
[TBL] [Abstract][Full Text] [Related]
6. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
7. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.
Wang H; Chen XP; Qiu FZ
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946
[TBL] [Abstract][Full Text] [Related]
8. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats.
Camara PR; Ferraz GJ; Franco-Penteado CF; Sbragia-Neto L; Meirelles LR; Teixeira SA; Muscara MN; Velloso LA; Antunes E; Ferraz JG
Eur J Pharmacol; 2008 Jul; 589(1-3):245-50. PubMed ID: 18555214
[TBL] [Abstract][Full Text] [Related]
9. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites.
Morales-Ruiz M; Jiménez W; Pérez-Sala D; Ros J; Leivas A; Lamas S; Rivera F; Arroyo V
Hepatology; 1996 Dec; 24(6):1481-6. PubMed ID: 8938184
[TBL] [Abstract][Full Text] [Related]
10. Increased blood flow through the portal system in cirrhotic rats.
Vorobioff J; Bredfeldt JE; Groszmann RJ
Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study on iNOS gene transfer mediated by liposome to treat portal hypertension in cirrhotic rats].
Qiu JF; Wu ZY; Zhang ZQ; Luo HF
Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):428-31. PubMed ID: 15144673
[TBL] [Abstract][Full Text] [Related]
12. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
13. Splanchnic endotoxin levels in cirrhotic rats induced by carbon tetrachloride.
Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Lu RH; Chan CC; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):196-204. PubMed ID: 10746415
[TBL] [Abstract][Full Text] [Related]
14. [Dexamethasone, an inhibitor of the expression of inducible nitric oxide synthase, does not modify the hyperdynamic state in cirrhotic rats].
Albornoz L; Bandi JC; de las Heras M; Mastai R
Medicina (B Aires); 2000; 60(4):477-81. PubMed ID: 11188955
[TBL] [Abstract][Full Text] [Related]
15. [Role of nitric oxide in alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension].
Albornoz L; Bandi JC; Sánchez S; Spinedi E; Canteros G; De Paula JA; Galdame O; Mastai R
Medicina (B Aires); 1994; 54(1):17-24. PubMed ID: 7990681
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats.
Islas-Carbajal MC; Covarrubias A; Grijalva G; Alvarez-Rodríguez A; Armendáriz-Borunda J; Rincón-Sánchez AR
Liver Int; 2005 Feb; 25(1):131-40. PubMed ID: 15698410
[TBL] [Abstract][Full Text] [Related]
18. Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.
Matei V; Rodríguez-Vilarrupla A; Deulofeu R; García-Calderó H; Fernández M; Bosch J; Garcia-Pagán JC
J Hepatol; 2008 Aug; 49(2):192-7. PubMed ID: 18534709
[TBL] [Abstract][Full Text] [Related]
19. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance.
Rockey DC; Weisiger RA
Hepatology; 1996 Jul; 24(1):233-40. PubMed ID: 8707268
[TBL] [Abstract][Full Text] [Related]
20. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]